Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 3 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings Inc | CRBP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 35.54 | 07:00:09 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 35.54 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 2 | 3 | - | 3.0334 - 49.8699 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:04:21 | 1 | $ 35.54 | USD |
Corbus Pharmaceuticals (CRBP) Options Flow Summary
Corbus Pharmaceuticals Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 362.22M | 10.49M | - | 0 | -44.6M | -4.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Corbus Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRBP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 36.17 | 40.08 | 34.24 | 37.56 | 245,569 | -0.63 | -1.74% |
| 1 Month | 35.42 | 45.00 | 34.24 | 38.90 | 241,019 | 0.12 | 0.34% |
| 3 Months | 25.90 | 49.8699 | 20.21 | 35.28 | 309,885 | 9.64 | 37.22% |
| 6 Months | 5.71 | 49.8699 | 3.0334 | 29.58 | 504,093 | 29.83 | 522.42% |
| 1 Year | 10.17 | 49.8699 | 3.0334 | 28.74 | 262,499 | 25.37 | 249.46% |
| 3 Years | 52.50 | 68.70 | 2.11 | 19.93 | 1,307,423 | -16.96 | -32.30% |
| 5 Years | 212.70 | 322.50 | 2.11 | 64.88 | 2,195,821 | -177.16 | -83.29% |
Corbus Pharmaceuticals Description
| Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. |
